Neural Correlates of Self

NCT ID: NCT03206840

Last Updated: 2025-11-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-10-26

Study Completion Date

2018-11-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Despite the increasing popularity of mindfulness meditation and hypnosis in healthcare and in the general community the underlying neurobiological mechanisms are unclear. The change in the relationship between the self and the conscious experience that they bring about may be crucial. This study aims to identify the neural correlates of self-consciousness in meta-awareness and absorption - using functional Magnetic Resonance Imaging (fMRI) in healthy participants combined with detailed first-person experiential accounts and behavioural tasks. This study will provide important clues about the widely reported effects of mindfulness meditation and hypnosis and shed light on the neural correlates of the conscious experience of self.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

three instructions will be given to each participant: "control", "meditation", "hypnosis". The order of "meditation" and "hypnosis" will be randomized amongst two groups to avoid order effects.

Group Type EXPERIMENTAL

"control", "meditation", "hypnosis".

Intervention Type BEHAVIORAL

three instructions will be given to each participant: "control", "meditation", "hypnosis". The order of "meditation" and "hypnosis" will be randomized amongst two groups to avoid order effects.

Group 2

three instructions will be given to each participant: "control", "meditation", "hypnosis". The order of "meditation" and "hypnosis" will be randomized amongst two groups to avoid order effects.

Group Type EXPERIMENTAL

"control", "meditation", "hypnosis".

Intervention Type BEHAVIORAL

three instructions will be given to each participant: "control", "meditation", "hypnosis". The order of "meditation" and "hypnosis" will be randomized amongst two groups to avoid order effects.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

"control", "meditation", "hypnosis".

three instructions will be given to each participant: "control", "meditation", "hypnosis". The order of "meditation" and "hypnosis" will be randomized amongst two groups to avoid order effects.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aged 18-70
* Body mass index between 18.5 and 30
* Covered by health insurance
* motivated to participate
* signed informed consent
* normal or corrected-to-normal eyesight
* sufficient command of French to be able to follow the instructions

Exclusion Criteria

* history of neurological or psychiatric conditions
* chronic pain or another medical condition altering pain perception
* use of medication that affects the central nervous system
* use of opioids or antidepressant medication
* severe auditory loss
* consumption of alcohol or intoxicants on the day of the experiments and the day preceding the experiments
* pregnancy, breastfeeding or having given birth \<6months ago
* any contra-indication to Magnetic Resonance Imaging (metal implants or foreign bodies), agitation, claustrophobia
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Antoine LUTZ, PhD

Role: PRINCIPAL_INVESTIGATOR

Lyon Neuroscience Research Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospices Civils de Lyon Hôpital le Vinatier/Inserm

Bron, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Lutz A. Regulation of attention and emotions by meditation: neurophysiological basis and implications for mental and physical health. In: 12th BIAL Foundation Symposium "Amplified states of consciousness"; 2018 Apr 6; Porto, Portugal. Lutz A. Méditation, hypnose… se soigner par la conscience. In: INSERM - Culture scientifique (webinar); 2022 Dec 13; Paris, France (online). Lutz A. Mindfulness meditation from the lenses of phenomenology and neurosciences. In: USC Center for Mindful Science - Invited lecture; 2022 Dec 12; Los Angeles (CA), USA. Lutz A. Neurophenomenology after Varela (1996). In: Metanoia/Ouroboros - Seminar; 2021 Sep 1; (online).

Reference Type RESULT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017-A01923-50

Identifier Type: OTHER

Identifier Source: secondary_id

69HCL17_0274

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Neural Mechanisms of Mindfulness
NCT03466164 COMPLETED NA
Neural Bases of the Check Process
NCT03483233 COMPLETED NA